Literature DB >> 19105584

The efficacy and safety of cilomilast in COPD. Forward.

Alvar Agusti1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 19105584     DOI： 10.2165/0003495-200868002-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  13 in total

1.  Management of chronic obstructive pulmonary disease: are we going anywhere?

Authors:  S Rennard; M Carrera; A G Agustí
Journal:  Eur Respir J       Date:  2000-12       Impact factor: 16.671

2.  Treating COPD--the TORCH trial, P values, and the Dodo.

Authors:  Klaus F Rabe
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245

3.  Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey.

Authors:  Bartolome R Celli; R J Halbert; Robert J Nordyke; Brigitte Schau
Journal:  Am J Med       Date:  2005-12       Impact factor: 4.965

Review 4.  Global burden of COPD: risk factors, prevalence, and future trends.

Authors:  David M Mannino; A Sonia Buist
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

5.  The global burden of disease, 1990-2020.

Authors:  A D Lopez; C C Murray
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

6.  Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study.

Authors:  C H Compton; J Gubb; R Nieman; J Edelson; O Amit; A Bakst; J G Ayres; J P Creemers; G Schultze-Werninghaus; C Brambilla; N C Barnes
Journal:  Lancet       Date:  2001-07-28       Impact factor: 79.321

Review 7.  COPD, a multicomponent disease: implications for management.

Authors:  A G N Agusti
Journal:  Respir Med       Date:  2005-01-08       Impact factor: 3.415

Review 8.  Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.

Authors:  Peter J Barnes; Kazuhiro Ito; Ian M Adcock
Journal:  Lancet       Date:  2004-02-28       Impact factor: 79.321

9.  A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Authors:  Donald P Tashkin; Bartolome Celli; Stephen Senn; Deborah Burkhart; Steven Kesten; Shailendra Menjoge; Marc Decramer
Journal:  N Engl J Med       Date:  2008-10-05       Impact factor: 91.245

10.  Chronic obstructive pulmonary disease in lifelong nonsmokers: results from NHANES.

Authors:  A S Whittemore; S A Perlin; Y DiCiccio
Journal:  Am J Public Health       Date:  1995-05       Impact factor: 9.308
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.